36th ECNP Congress 2023
Date and time: 7-10 October 2023 Location Barcelona, Spain
36th ECNP Congress 2023 Read More »
ISCTM Autumn Conference with ECNP 2023
Date and time: 5-7 October 2023 Location Barcelona, Spain
ISCTM Autumn Conference with ECNP 2023 Read More »
CANTAB Mobile: experience of use of a digital memory screening tool in primary care
Publications & posters Back to resource centre 11 January 2023 CANTAB Mobile: experience of use of a digital memory screening tool in primary care Early identification of memory complaints in clinical settings can aid identification of deficits, or reassurance, and can support care planning and management. CANTAB Mobile combines a sensitive touchscreen memory test, with a depression screen to differentiate
CANTAB Mobile: experience of use of a digital memory screening tool in primary care Read More »
Evaluating the challenges and benefits of fully decentralized and hybrid clinical trials
Back to resource centre Evaluating the challenges and benefits of fully decentralized and hybrid clinical trials A pan-European interventional study to enrol Diabetes Mellitus (DM) patientsThe RADIAL concept study aims to generate delivering scientific evidence and data on the benefits and challenges of running a DCT Clinpal is the core platform for this in a 3-arm (conventional, hybrid, remote) clinical trial
Study in Psoriasis
Back to resource centre A digitised version of the SAPASI instrument, allowing researchers to monitor and record moderate-to-severe plaque psoriasis in clinical trial patients Leveraging Wake Forest’s validated diagnostic tool, the Self-administered Psoriasis Area Severity Index (SAPASI) ePRO prompts patients using the standard Clinpal app on their bring-your-own devices, at protocol-specified time intervals, to manually mark where their psoriasis is on
Study in Psoriasis Read More »
Validation Study to Assess the Adherence of RA Patients Taking MTX
Back to resource centre Validation Study to Assess the Adherence of RA Patients Taking MTX A multi-centre psychometric validation study, led by Roche, to validate a PRO tool (MEQ) to assess medication adherence in rheumatoid arthritis (RA) for patients being treated with Methotrexate (MTX).Once recruited, patients completed the MEQ and two generic compliance questionnaires to self-reported adherence. Physicians of the
Validation Study to Assess the Adherence of RA Patients Taking MTX Read More »
CANTAB Recruit: A quicker, more cost-effective way of finding the right patients for clinical trials
Back to resource centre CANTAB Recruit: A quicker, more cost-effective way of finding the right patients for clinical trials Key achievementsUsing the online CANTAB Recruit assessment our customer screened out over 85% of their participants who would be ineligible for their Alzheimer’s trial, saving time and money.High compliance rates of 90% were seen when screening an aging population taking assessments
Measuring cognition in areas outside of the Central Nervous System
Insights Back to resource centre 24 April 2023 Measuring cognition in areas outside of the Central Nervous System CANTAB® cognitive assessments are often used to measure cognition in disorders of the Central Nervous System, but did you know that they are also used in research that don’t involve the CNS? Here, two research teams explain how CANTAB is supporting their
Measuring cognition in areas outside of the Central Nervous System Read More »
Speech phenotypes in cognitively healthy participants at risk of developing Alzheimer’s disease
Insights Back to resource centre 4 April 2023 Speech phenotypes in cognitively healthy participants at risk of developing Alzheimer’s disease This poster was presented at AD/PD in March 2023 and represents collaborative work between Winterlight Labs and Novartis. Poster SummaryChanges to speech patterns have been identified as early signs of Alzheimer’s Disease (AD) and have been shown to progress with
